Ross Moat - Net Worth and Insider Trading
Ross Moat Net Worth
The estimated net worth of Ross Moat is at least $485,148 dollars as of 2024-11-29. Ross Moat is the CHIEF COMMERCIAL OFFICER of Kiniksa Pharmaceuticals International PLC and owns about 21,736 shares of Kiniksa Pharmaceuticals International PLC (KNSA) stock worth over $485,148. Details can be seen in Ross Moat's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ross Moat has not made any transactions after 2024-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ross Moat
Ross Moat Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ross Moat owns 1 companies in total, including Kiniksa Pharmaceuticals International PLC (KNSA) .
Click here to see the complete history of Ross Moat’s form 4 insider trades.
Insider Ownership Summary of Ross Moat
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International PLC | 2024-09-03 | Group VP & Rilonacept GM |
Ross Moat Latest Holdings Summary
Ross Moat currently owns a total of 1 stock. Ross Moat owns 21,736 shares of Kiniksa Pharmaceuticals International PLC (KNSA) as of September 3, 2024, with a value of $485,148.
Latest Holdings of Ross Moat
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International PLC | 2024-09-03 | 21,736 | 22.32 | 485,148 |
Holding Weightings of Ross Moat
Ross Moat Form 4 Trading Tracker
According to the SEC Form 4 filings, Ross Moat has made a total of 1 transactions in Kiniksa Pharmaceuticals International PLC (KNSA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Kiniksa Pharmaceuticals International PLC is the sale of 68,506 shares on September 3, 2024, which brought Ross Moat around $2 Million.
Insider Trading History of Ross Moat
- 1
Ross Moat Trading Performance
Ross Moat Ownership Network
Ross Moat Owned Company Details
What does Kiniksa Pharmaceuticals International PLC do?
Who are the key executives at Kiniksa Pharmaceuticals International PLC?
Ross Moat is the Group VP & Rilonacept GM of Kiniksa Pharmaceuticals International PLC. Other key executives at Kiniksa Pharmaceuticals International PLC include Chief Business Officer Eben Tessari , director & 10 percent owner & Chairman & CEO Sanj K Patel , and Chief Medical Officer John Paolini .
Kiniksa Pharmaceuticals International PLC (KNSA) Insider Trades Summary
Over the past 18 months, Ross Moat made 1 insider transaction in Kiniksa Pharmaceuticals International PLC (KNSA) with a net sale of 68,506. Other recent insider transactions involving Kiniksa Pharmaceuticals International PLC (KNSA) include a net sale of 150,848 shares made by John Paolini , a net sale of 309,021 shares made by Sanj K Patel , and a net sale of 69,000 shares made by Eben Tessari .
In summary, during the past 3 months, insiders sold 270,259 shares of Kiniksa Pharmaceuticals International PLC (KNSA) in total and bought 0 shares, with a net sale of 270,259 shares. During the past 18 months, 645,724 shares of Kiniksa Pharmaceuticals International PLC (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 645,724 shares.
Kiniksa Pharmaceuticals International PLC (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals International PLC Insider Transactions
Ross Moat Mailing Address
Above is the net worth, insider trading, and ownership report for Ross Moat. You might contact Ross Moat via mailing address: C/o Kiniksa Pharmaceuticals Ltd., Clarendon House, 2 Church Street, Hamilton D0 Hm11.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
